Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir-Reference-Cited by-同舟云学术

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

Published:2016-09 Issue:3 Volume:151 Page:501-512.e1
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sarrazin Christoph,Dvory-Sobol Hadas,Svarovskaia Evguenia S.,Doehle Brian P.,Pang Phillip S.,Chuang Shu-Min,Ma Julie,Ding Xiao,Afdhal Nezam H.,Kowdley Kris V.,Gane Edward J.,Lawitz Eric,Brainard Diana M.,McHutchison John G.,Miller Michael D.,Mo Hongmei

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Current and future therapies for hepatitis C virus infection;Liang;N Engl J Med,2013

2. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

3. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

4. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis;Kowdley;N Engl J Med,2014

5. Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial;Lawitz;Lancet,2014

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications;Microorganisms;2024-05-17

3. Molecular characterization of the nonstructural 5A (NS5A) region of hepatitis C virus in Thai blood donors;Archives of Microbiology;2024-04-15

4. A Systematic Review on the Evolution of Natural Mutation-dependent Antiviral Drug Resistance in Hepatitis C Virus (HCV) Genotypes Prevalent in Saudi Arabia: A Genomic and Therapeutic Perspective;The Natural Products Journal;2024-04-03

5. Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an in vivo infectious 3b cDNA clone;Journal of Virology;2023-12-21